Guru Ownership Trend
Guru Analysis for Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences, Inc. (RCUS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $41.22 M.
Top institutional holders include Ken Fisher and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $18.29 M net outflow during the quarter.
On the selling side, Cliff Asness reduced exposure by 2.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Arcus Biosciences, Inc. (RCUS)
Major holders include Ken Fisher ($65.96 M), Cliff Asness ($2.59 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 2.22 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $18.29 M, with 0 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 3 fully exited RCUS. The total reported sell value was $18.29 M.
No tracked managers opened new positions or increased their holdings in RCUS during the most recent reporting period.